RBC Capital Maintains Sector Perform on Amneal Pharmaceuticals, Raises Price Target to $4

RBC Capital analyst Randall Stanicky maintains Amneal Pharmaceuticals (NYSE:AMRX) with a Sector Perform and raises the price target from $3 to $4.

Benzinga · 01/02/2020 16:31

RBC Capital analyst Randall Stanicky maintains Amneal Pharmaceuticals (NYSE:AMRX) with a Sector Perform and raises the price target from $3 to $4.